CLPX and glioblastoma: We observed that IRT triple combination treatment induces PKA substrate phosphorylation, induces ATF4/ISR activation, and inhibits ClpX to unleash ClpP, and multiple markers of cell death in treated in SNB19, T98G, U138, and U251 GBM cell lines.